Reviva Pharmaceuticals
RVPH
RVPH
45 hedge funds and large institutions have $5.44M invested in Reviva Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
22% less capital invested
Capital invested by funds: $6.94M → $5.44M (-$1.5M)
Holders
45
Holding in Top 10
–
Calls
$2.25M
Puts
$23K
Top Buyers
| 1 | +$1.03M | |
| 2 | +$794K | |
| 3 | +$697K | |
| 4 |
6CM
683 Capital Management
New York
|
+$381K |
| 5 |
PAP
Persistent Asset Partners
Hong Kong
|
+$183K |
Top Sellers
| 1 | -$487K | |
| 2 | -$206K | |
| 3 | -$191K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$84.9K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$58.1K |
